Atirmociclib Clinical Trials

3 actively recruiting trials across 3 locations

No change since August 2026

Also known as: CDK4i, PF-07220060

Pipeline

Phase 1: 1Phase 2: 1Phase 1/2: 1

Top Sponsors

Pfizer1
Hoffmann-La Roche1
AstraZeneca1

Indications

Breast Cancer2
Cancer2
Healthy, Hepatic Insufficiency1
Liver Disease1
Healthy Adults1

Duarte, California1 trial

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

City of Hope - Duarte

Phase 1/2

Miami Lakes, Florida1 trial

A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease

Floridian Clinical Research

Phase 1

St Louis, Missouri1 trial

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.